open access
Liraglutide therapy in an adolescent with Prader‑Willi syndrome and concomitant diabetes mellitus
Affiliations- Xi’an Central Hospital, The Affiliated Hospital of Xi’an Jiaotong University College of Medicine, Xi’an, Shanxi, China
open access
Abstract
Not required for Clinical Vignette.
Abstract
Not required for Clinical Vignette.
Keywords
adolescent; diabetes mellitus; liraglutide; Prader-Willi syndrome
About this articleTitle
Liraglutide therapy in an adolescent with Prader‑Willi syndrome and concomitant diabetes mellitus
Journal
Issue
Article type
Clinical vignette
Pages
219-220
Published online
2023-02-21
Page views
2104
Article views/downloads
433
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2023;74(2):219-220.
Keywords
adolescent
diabetes mellitus
liraglutide
Prader-Willi syndrome
Authors
Ming Li
Nan Li
Zhufang Tian
Xiang Wang
References (4)- Mahmoud R, Singh P, Weiss L, et al. Newborn screening for Prader-Willi syndrome is feasible: Early diagnosis for better outcomes. Am J Med Genet A. 2019; 179(1): 29–36.
- Cho SY, Kang D, Im M, et al. Development and validation of the Pediatric-Youth Hyperphagia Assessment for Prader-Willi syndrome. Epidemiol Health. 2022; 44: e2022014.
- Zheng W, Li L, Li H. Phytochemicals modulate pancreatic islet β cell function through glucagon-like peptide-1-related mechanisms. Biochem Pharmacol. 2022; 197: 114817.
- Ng NB, Low YW, Rajgor DD, et al. The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review. Clin Endocrinol (Oxf). 2022; 96(2): 144–154.
